Patent US5309896A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4213962A Expired / Lapsed US ⏱️ 0.0 years remaining

Artificial medical material with anticoagulative activity

Assignee: Individual
•
Filing: 1978-07-25
•
Granted: 1980-07-22
•
Expires: 1998-07-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An artificial medical material with an anticoagulative activity which comprises a carrier material, and heparin and antithrombin III co-immobilized thereon by a per se conventional procedure.

Inventors

  • 👤 Yoshiharu Miura
  • 👤 Sadayoshi Aoyagi
  • 👤 Kazuhisa Miyamoto

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 07:40
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; A61K38/00; A61K38/005; Y; Y10; Y10S; Y10S530/00; Y10S530/81; Y10S530/812; Y10S530/815

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 19 words
An artificial medical material with anticoagulative activity which comprises a carrier material with heparin and antithrombin III co-immobilized thereon.
Claim 2
Dependent Claim 19 words
An artificial medical material with anticoagulative activity which comprises a carrier material with heparin and antithrombin III co-immobilized thereon.
Claim 3
Dependent Claim 17 words
An artificial medical material according to claim 1, wherein the carrier material is a water-insoluble high polymer.
Claim 4
Dependent Claim 15 words
An artificial medical material according to claim 2, wherein the water-insoluble high polymer is agarose.
Claim 5
Dependent Claim 16 words
An artificial medical material according to claim 2, wherein the water-insoluble high polymer is polyvinyl alcohol.
Claim 6
Dependent Claim 16 words
An artificial medical material according to claim 2, wherein the water-insoluble high polymer is polyhydroxyethyl methacrylate.
Claim 7
Dependent Claim 16 words
An artificial medical material according to claim 1, wherein the carrier material is activated carrier material.
Claim 8
Dependent Claim 16 words
An artificial medical material according to claim 6, wherein the carrier material is cyanogen-bromide-activated carrier material.
Claim 9
Dependent Claim 23 words
An artificial medical material according to claim 1, wherein the proportion of heparin and antithrombin III is from 1:1 to 10:1 (by weight).
Claim 10
Dependent Claim 35 words
An artificial medical material according to claim 1, wherein heparin and antithrombin III are immobilized on the carrier material, respectively, in amounts of from 1 to 50 mg per 1 g of the carrier material.
Claim 11
Dependent Claim 22 words
A method for prevention of coagulation of blood which comprises contacting the blood with an artificial medical material according to claim 1.
Claim 12
Dependent Claim 24 words
A method for inactivation of the Xa factor in blood which comprises contacting the blood with an artificial medical material according to claim 1.
Claim 13
Dependent Claim 45 words
In a method for prevention of coagulation of blood by contacting the blood with an artificial medical material bearing heparin immobilized thereon, the improvement wherein the artificial medical material also bears antithrombin III immobilized thereon so that the anticoagulative activity of heparin is greatly enhanced.
Claim 14
Dependent Claim 45 words
In a method for prevention of coagulation of blood by contacting the blood with an artificial medical material bearing heparin immobilized thereon, the improvement wherein the artificial medical material also bears antithrombin III immobilized thereon so that the anticoagulative activity of heparin is greatly enhanced.
Claim 15
Dependent Claim 17 words
A combination of immobilized heparin and an anticoagulative-activity-enhancing amount of immobilized antithrombin III on a carrier material.
Claim 16
Dependent Claim 17 words
A combination of immobilized heparin and an anticoagulative-activity-enhancing amount of immobilized antithrombin III on a carrier material.

References Cited (Backward Citations)

JPS4938945A Cited
JPS5236779A Cited
US4048064A Cited
US4073723A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-07-22 1984-01-21 1984-07-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-07-22 1988-01-21 1988-07-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-07-22 1992-01-21 1992-07-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag